XML 72 R56.htm IDEA: XBRL DOCUMENT v3.25.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of equity method investments (Details) - USD ($)
$ in Thousands
 2 Months Ended 3 Months Ended
Dec. 31, 2024
Mar. 31, 2025
Dec. 31, 2024
Mar. 31, 2024
Dec. 31, 2023
Mar. 10, 2025
Sep. 30, 2024
Schedule of Equity Method Investments [Line Items]              
Equity attributable to investee $ (488,175) $ (496,817) $ (488,175)        
Noncontrolling interest   1,575       $ 1,575  
Revenues   186,063   $ 297,590      
Loss from continuing operations   (19,962)   (61,301)      
Net loss attributable to investees   $ (9,975)   $ (49,165)      
FRG              
Schedule of Equity Method Investments [Line Items]              
Current assets             $ 871,102
Noncurrent assets             2,889,334
Current liabilities             569,281
Noncurrent liabilities             2,680,178
Revenues         $ 806,229    
Cost of revenues         499,679    
Loss from continuing operations         (1,175)    
FRG | Investee              
Schedule of Equity Method Investments [Line Items]              
Equity attributable to investee             510,977
Net loss attributable to investees         (169,583)    
B&W              
Schedule of Equity Method Investments [Line Items]              
Current assets 490,185   490,185       530,223
Noncurrent assets 236,802   236,802       274,410
Current liabilities 388,493   388,493       297,928
Noncurrent liabilities 621,666   621,666       709,823
Noncontrolling interest 591   591       576
Revenues     66,276   227,167    
Cost of revenues     42,043   171,552    
Loss from continuing operations     (71,318)   (54,266)    
Net loss attributable to investees     (63,021)   (62,724)    
B&W | Investee              
Schedule of Equity Method Investments [Line Items]              
Equity attributable to investee (283,763)   (283,763)       (203,694)
Net loss attributable to investees     (63,065)   (66,454)    
Synchronoss Technologies, Inc.              
Schedule of Equity Method Investments [Line Items]              
Revenues         41,402    
Cost of revenues         10,292    
Synchronoss Technologies, Inc. | Investee              
Schedule of Equity Method Investments [Line Items]              
Net loss attributable to investees         (35,001)    
Other Equity Investments              
Schedule of Equity Method Investments [Line Items]              
Current assets 20,552   20,552       215,927
Noncurrent assets 119,695   119,695       572,628
Current liabilities 9,827   9,827       86,672
Noncurrent liabilities 69,309   69,309       105,711
Revenues     11,723   145,974    
Cost of revenues     2,794   127,348    
Other Equity Investments | Investee              
Schedule of Equity Method Investments [Line Items]              
Equity attributable to investee 61,111   61,111       $ 596,172
Net loss attributable to investees     (2,314)   $ (10,505)    
GA Holdings              
Schedule of Equity Method Investments [Line Items]              
Current assets 34,922   34,922        
Noncurrent assets 291,362   291,362        
Current liabilities 34,735   34,735        
Noncurrent liabilities 279,096   279,096        
Revenues 21,675            
Cost of revenues 18,184            
GA Holdings | Investee              
Schedule of Equity Method Investments [Line Items]              
Equity attributable to investee 12,453   $ 12,453        
Net loss attributable to investees $ 3,490